Barbara Kazmierczak
Barbara Irene Kazmierczak is an American microbiologist. She is the Gustavus and Louse Pfeiffer Research Foundation MD-PhD Program Director at the Yale School of Medicine. Kazmierczak is also a professor of medicine and professor of microbial pathogenesis.
Barbara Kazmierczak | |
---|---|
Academic background | |
Education | Diploma, Maine South High School B.A., University of Chicago PhD., Rockefeller University MD., Cornell University Medical College |
Academic work | |
Institutions | Yale School of Medicine. |
Career
Kazmierczak joined the faculty at Yale School of Medicine in 2001.[1] The next year, she was the recipient of the 2002 Donaghue Investigator Program award from the Donaghue Medical Research Foundation for her research on how human cells respond to disease-causing bacteria.[2]
In 2014, she was named Director at the Yale Medical Scientist Training Program, replacing James D. Jamieson.[1] By 2019, Kazmierczak was appointed to the Gustavus and Louise Pfeiffer Research Foundation M.D.-Ph.D. Program Director endowed professorship.[3] She was also elected a fellow of the American Academy of Microbiology[4] and named president of the National Association of MD-PhD Programs and chair of the AAMC's GREAT Group MD-PhD Steering Committee.[5]
References
- "For Yale's renowned M.D./Ph.D. Program, a changing of the guard". medicine.yale.edu. 2014. Retrieved November 13, 2019.
- "Two Yale Researchers Receive Donaghue Investigator Award". news.yale.edu. October 18, 2002. Retrieved November 13, 2019.
- "Dr. Barbara Kazmierczak named the Pfeiffer M.D.-Ph.D. Program Director". news.yale.edu. April 8, 2019. Retrieved November 13, 2019.
- "Kazmierczak and Turner elected fellows of American Academy of Microbiology". news.yale.edu. February 27, 2019. Retrieved November 13, 2019.
- @YaleMD (September 3, 2019). "Dr. Barbara Kazmierczak was named president, National Association of MD-PhD Programs and chair, MD-PhD Steering Committee of the @AAMCtoday GREAT Group. Way to go, Dr. Kazmierczak! 👏 #YaleInfectiousDiseases" (Tweet) – via Twitter.